Notably, more efficient silencing corresponded to progressively increased proliferative capabilities, underscoring the dose-dependent effect of C/EBPδ on pancreatic adenocarcinoma cell behavior. The gene discussed is CEBPD; the disease is pancreatic adenocarcinoma.